KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage
In This Article:
The deal values the Swedish company at $1.2 billion, and the Biotage board recommended that shareholders accept the offer.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
The deal values the Swedish company at $1.2 billion, and the Biotage board recommended that shareholders accept the offer.